Kratom addiction alarm grows in US as RFK Jr targets 7-OH: What is it and how can it impact your health?
The FDA is considering scheduling 7-OH, a kratom byproduct, as an illicit drug due to addiction risks. Kratom, sold as a supplement for pain relief and energy, is available nationwide in various forms. Concerns are rising about its addictive potential, likened to opioids, especially with products containing concentrated 7-OH. An uptick in 7-OH-related medical events has led the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to crack down on sellers of these products.
Kratom has gained massive popularity in the US following a viral TikTok video and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr's recent press conference. Kratom is in the spotlight in the United States. Kratom is a tropical tree (Mitragyna speciosa) that is native to Southeast Asia and products prepared from kratom leaves are available in the U.S. through sales on the Internet and at brick-and-mortar stores, according to the Food and Drug Administration (FDA)Kratom is often used to self-treat conditions such as pain, coughing, diarrhea, anxiety and depression, opioid use disorder, and opioid withdrawal. Last week, FDA Commissioner Marty Makary announced that the Trump administration has recommended that a compound called 7-OH be scheduled as an illicit drug. The compound is a by-product of the Kratom plant whose ground leaves are sold as a dietary supplement to boost energy or provide pain relief.
According to USA Today, products containing the plant ingredient kratom are sold across the country at gas stations, liquor stores and smoke shops. They come in drinks, capsules and powders with medical experts having warned that it can be highly addictive, producing effects similar to those of opioids and opiates. They are available in three forms: beverages, capsules, and powder and some are even available in brightly colored packaging.
ALSO READ: Blue whales' mysterious silence leave scientists worried as it sends a dire warning to humanity
Kratom has gained massive popularity in the US following a viral TikTok video and Health and Human Services (HHS) Secretary Robert F. Kennedy Jr's recent press conference. Dr. Timothy Fong, a UCLA addiction psychiatrist, told USA Today the ability of companies to put large amounts of kratom into otherwise innocuous-looking products has made it more susceptible to abuse. During a July 29 press conference, Food and Drug Administration commissioner Martin Makary announced the organization's intention to crackdown on products containing 7-OH; however, Makary also made clear during that press conference that the organization's focus is on 7-OH, not kratom overall.
ALSO READ: Uber shocks Wall Street with massive $20 billion buyback: What it means and why companies do it
FDA officials said 7-OH has a 'high risk of addiction' and abuse because of its ability to bind to opioid receptors in the brain. The compound is found in trace amounts in the kratom plant, and the FDA's move is aimed at products with concentrated levels of 7-OH. 'We have a history in public health of being asleep at the wheel,' Makary said. 'Public health is supposed to prevent disasters, not just clean them up after they've killed thousands and thousands of people.' 'Today, we're taking action on 7-OH as a critical step in the fight against opioid addiction,' RKF Jr said during a July 29 press conference. 'We will protect the health of our nation's youth as we advance our mission to Make America Healthy Again.'"I spent 14 years a heroin addict, and I've been 43 years in recovery," Kennedy said during the press conference. "I've had iron willpower for most of my life. ... This compulsion was absolutely impervious to my will, and part of the problem was just the availability."Makary alongside with RFK Jr announced their plan to initiate the process to have 7-OH scheduled as an illicit substance. That will happen if the Drug Enforcement Administration approves the FDA's sanction after review.
ALSO READ: ESPN adds WWE's WrestleMania, Royal Rumble as streaming service sets August 21 launch. Check details
Medical experts told USA TODAY that while kratom and 7-OH remain largely understudied, all kratom products pose a risk of addiction—not just those marketed with 7-OH. Some individuals said their dependency was solely on kratom-based products and that they had never used ones containing synthetic 7-OH. For others, kratom use served as a gateway to trying products with synthetic 7-OH.Though there are multiple kratom products on the market, but one particular drink has gone viral in recent weeks. On July 25, a TikToker under the name @yourbestimisha posted a video that now has over 19 million views, in which he described how a teenage boy tried stealing his wallet outside a gas station after he refused to go inside to buy the boy a Feel Free tonic containing kratom. A representative for Botanic Tonics, the company behind Feel Free, told USA TODAY its Feel Free Classic tonic contains only natural leaf kratom, with nearly undetectable levels of 7-OH.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
6 hours ago
- Time of India
Indian-origin Dr Vinay Prasad returns to FDA weeks after exit; Laura Loomer calls it 'egregious decision'
Dr Vinay Prasad is back at his FDA job weeks after exit that was prompted by right-wing activist Laura Loomer's campaigning against Prasad. Dr Vinay Prasad, the Indian-origin vaccine chief of the FDA who was forced to resign in July after far-right activist Laura Loomer led a campaign against him, has been reinstated to his job in an unusual instance. Laura Loomer pointed out the critical comments that Dr Prasad made about President Donald Trump before joining the administration, while some of his decisions to deny drug approvals also came under fire. A Department of Health and Human Services spokesperson confirmed to the New York Times that Dr Prasad is returning to the agency. 'At the F.D.A.'s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Andrew Nixon, a health department spokesman, said in a statement. The NYT report observed that Dr Prasad's rehiring suggests that the health secretary, Robert F Kennedy Jr., and the FDA commissioner, Dr Marty Makary, remain influential enough in the Trump administration to employ someone who had previously expressed disdain for Trump and his followers. Loomer reacted to the reinstatement and called in another "egregious personnel decision". "In another egregious personnel decision under the Trump administration, it is now being reported that longtime progressive Marxist Vinay Prasad who referred to President Trump's supporters as criminals and compared them to drug addicts after saying he stabbed a Trump voodoo doll to 'curse Trump' is apparently back at FDA," Loomer wrote. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Everyone is suddenly using this AI language learning app Talkpal AI Learn More Undo RFK Jr tapped Dr Prasad in May when the previous head of the FDA's Center for Biologics Evaluation left the role. During the Covid-19 pandemic, Dr Prasad gained prominence as an outspoken critic of vaccines and mask mandate. In his short stint at the FDA since May, Dr Prasad limited the use of Covid-19 vaccines and promoted warnings about a rare side effect of the vaccines. When he resigned from his role weeks ago, a department spokesperson told the NYT: "Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family." Kennedy, however, opposed Prasad's departure from the role and remained invested in bringing him back. Dr Prasad was born and brought up in Ohio and Chicago to Indian immigrant parents.
India Today
14 hours ago
- India Today
Vinay Prasad returns as US vaccine regulator chief days after stepping down
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the US Food and Drug Administration a little more than a week after he left the agency."At the FDA's request, Dr Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research," US Health and Human Services spokesperson Andrew Nixon said in an emailed statement to left the agency on July 30 after just a few months as director of the center. Endpoints News first reported the return of an oncologist who was a fierce critic of US COVID-19 vaccine and mask mandates, was named the center's director by FDA Commissioner Marty Makary in of Prasad's tenure intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy from Sarepta Therapeutics FDA-approved therapy played a role in the death of two teens who had advanced DMD. After a third death in a separate experimental gene therapy from the company, the FDA asked Sarepta on July 18 to stop all shipments of the approved DMD therapy, saying it had safety FDA changed course on Sarepta on July 28 and said shipments to the main group of patients for the drug could Loomer, a far-right activist and an ally of US President Donald Trump, posted a blog on July 20 in which she called Prasad a "progressive leftist saboteur" who was undermining the agency's was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of FDA and other health agencies have seen multiple shake-ups in recent months under the leadership of US Health Secretary Robert F Kennedy Jr.- Ends
Hindustan Times
18 hours ago
- Hindustan Times
FDA: No action against hotels based on social media posts alone
Food and Drug Administration (FDA) Pune region has announced that it will not take action against hotels and eateries solely on the basis of videos or posts shared on social media, said officials on Saturday, adding that formal complaint is mandatory. In recent months, several videos alleging poor hygiene and food safety violations at restaurants have gone viral. (REPRESENTATIVE PHOTO) 'With advances in technology, there is a possibility that such videos could be digitally altered or even AI-generated,' said Suresh Annapure, joint commissioner, FDA, Pune region. 'Posts on social media are not a legal process in case of food safety and hygiene violations. For swift action, people must register complaints with details. If a customer has faced or come across a violation of any Food Safety and Standards Act (FSS), 2006 and FSS Regulations, 2011, they should file a complaint with FDA,' he said. In recent months, several videos alleging poor hygiene and food safety violations at restaurants have gone viral. However, FDA pointed out that no official complaint makes it difficult to initiate action. Officials said suo moto inspection was carried out based on complaints. According to officials, following a customer complaint of a dead cockroach found in a bowl of soup at Bhiwandi Darbar Hotel in Camp in July, FDA visited the eatery and temporarily suspended the food licence. FDA has urged citizens to submit written or online complaints, besides using toll-free helpline 1800222365.
